MiNK Therapeutics Inc. (INKT)
NASDAQ: INKT
· Real-Time Price · USD
15.29
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
14.90
-2.55%
After-hours: Aug 15, 2025, 07:55 PM EDT
MiNK Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.77B | -2.46M | -1.81M | -2.7M | -3.81M | -5.46M | -5.12M | -6.2M | -5.69M | -7.77M | -6.33M | -6.11M | -7.78M | -5.76M | -14.27M | -6.34M | -3.85M |
Depreciation & Amortization | 50.77M | 53.87K | 62.64K | 45.1K | 53.83K | 53.57K | 53.45K | 51.91K | 45.69K | 37.93K | 28.43K | 28.31K | 27.08K | 23.83K | 20.29K | 17.65K | 16.19K |
Stock-Based Compensation | 591.09M | 390.05K | 883K | 436.87K | 592.01K | 1.1M | 939.26K | 898.26K | 921.14K | 667.63K | 772.9K | 800.81K | 785.51K | 667.03K | 387.36K | 407.3K | 283.03K |
Other Working Capital | n/a | -395.6K | 787.35K | 205.14K | 1.05M | 1.64M | 492.71K | 2.48M | 198.89K | 2.06M | -564.61K | 2.48M | 2.13M | 1.97M | 1.22M | 1.11M | -414.15K |
Other Non-Cash Items | n/a | 312.97K | -2.07M | 8.79K | 1.13M | 1.58M | -939K | -266.78K | 858.59K | 5.98B | 349.59K | -2.79M | 197.43K | 49.43K | 10.11M | 1.96M | 59.26K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.58M | 939K | n/a | -858.59K | -5.98B | -349.59K | n/a | n/a | n/a | -355.51K | n/a | n/a |
Change in Working Capital | n/a | -21.45K | -60K | -79.63K | 620.81K | 1.27M | -85.6K | 1.36M | 352.81K | 2.63M | -84.44K | 3.45M | 2.77M | 3.32M | 610.26K | 525.08K | -720.96K |
Operating Cash Flow | -1.34B | -1.73M | -2.99M | -2.29M | -2.54M | -3.04M | -4.21M | -4.15M | -4.37M | -4.43M | -5.61M | -4.63M | -4.2M | -1.7M | -3.5M | -3.42M | -4.21M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 73.56K | -23.04K | -37.02K | -13.5K | -127.84K | -59.8K | -62.41K | n/a | 277.00 | -111.82K | -97.92K | -39.52K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -73.56M | n/a | n/a | -13.5M | -250.05M | n/a | n/a | n/a | -248.98M | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -73.49M | -23.04K | -37.02K | -13.5K | -127.84K | -59.8K | -62.41K | n/a | 277.00 | -111.82K | -97.92K | -39.52K |
Debt Repayment | n/a | n/a | n/a | n/a | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -76 | 2.78M | 4.35M | 2.32M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -2 | 2.00 | -97.72K | -379.92K | -157.19K | n/a | -157.19K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 576K | -3 | 6.8K | 6.29K | 6.9K | n/a | 2.95K | 22.02K | 45.5K | 111.00 | 494.00 | 301.00 | 689.00 | 39.8M | 150.00 | n/a | n/a |
Financial Cash Flow | 576K | -3 | 6.8K | 5.81M | 5.01M | -2 | 2.95K | -75.7K | -334.43K | 111.00 | 494.00 | -156.89K | 689.00 | 39.8M | 2.78M | 4.35M | 2.32M |
Net Cash Flow | -1.34B | -1.75M | -2.99M | 3.5M | 2.45M | -3.03M | -4.22M | -4.27M | -4.74M | -4.52M | -5.69M | -4.84M | -4.2M | 38.07M | -838.9K | 848.07K | -1.88M |
Free Cash Flow | -1.34B | -1.73M | -2.99M | -2.29M | -2.54M | -2.96M | -4.23M | -4.19M | -4.38M | -4.56M | -5.67M | -4.69M | -4.2M | -1.7M | -3.61M | -3.52M | -4.25M |